Olav Dalgård - Infectious Diseases

Author Information

Olav Dalgård is affiliated with the Department of Infectious Diseases at Akershus University Hospital in Lørenskog, Norway. He is also associated with the Institute of Clinical Medicine at the University of Oslo in Oslo, Norway. His expertise lies in the field of infectious diseases, with a significant focus on hepatitis and viral infections.

Research Contributions

Olav Dalgård has made substantial contributions to the understanding and treatment of hepatitis, particularly hepatitis C virus (HCV) infection. His research encompasses a range of topics including the global prevalence of hepatitis C, innovative care models for HCV treatment among people who inject drugs, and the clinical implications of liver fibrosis. He has also investigated the outcomes of antiviral treatments in the context of the COVID-19 pandemic, contributing to studies on remdesivir, hydroxychloroquine, and their effects on viral clearance and patient outcomes. His work is pivotal in improving integrated treatment approaches and understanding the dynamics of hepatitis reinfection.

Aliases

Throughout his career, Olav Dalgård has been referenced by several aliases including "O Dalgard," "O. Dalgard," and "Olav Dalgård." These variations are commonly seen in academic and professional publications.

Publication and Citation Metrics

Metric Value
Total Citation Count 8,281
h-index 37
Total Number of Papers 154

Publications:

Partnered Content Networks

Relevant Topics